Short Interest in Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) Decreases By 16.2%

Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) was the recipient of a large drop in short interest in February. As of February 28th, there was short interest totalling 2,282,900 shares, a drop of 16.2% from the February 13th total of 2,723,600 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is currently 22,829.0 days.

Genomma Lab Internacional Stock Performance

Shares of OTCMKTS:GNMLF remained flat at $1.43 during midday trading on Tuesday. Genomma Lab Internacional has a 12 month low of $0.79 and a 12 month high of $1.43. The firm’s 50-day moving average price is $1.36 and its two-hundred day moving average price is $1.24.

About Genomma Lab Internacional

Genomma Lab Internacional, SAB. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Latin America. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and sexual improvement, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, and infant nutrition.